Progenity's Private Equity Round

Progenity raised a round of funding on August 16, 2016. Investors include Athyrium Capital Management.

Progenity, formerly Ascendant MDX, is a biotechnology company with a presence in Women's Health molecular testing and a pipeline of proprietary tests and therapeutic applications under development. Pr…

Articles about Progenity's Private Equity Round: